Literature DB >> 28889386

Patient-Derived Bladder Cancer Xenografts.

Carina Bernardo1,2, Lúcio Lara Santos3,4.   

Abstract

Patient-derived xenograft (PDX ) tumors are models developed by direct transplant of human tumors into immune-compromised hosts such as nude mice. These models retain the histological and genetic characteristics of the primary tumor and are considered a valuable platform for translational cancer research. This chapter describes the methodology to establish and propagate bladder cancer PDX model.

Entities:  

Keywords:  Animal models; Bladder cancer; Drug testing; In vivo; Tumorgraft; Xenograft

Mesh:

Substances:

Year:  2018        PMID: 28889386     DOI: 10.1007/978-1-4939-7234-0_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines.

Authors:  Tahlita C M Zuiverloon; Florus C de Jong; James C Costello; Dan Theodorescu
Journal:  Bladder Cancer       Date:  2018-04-26

2.  Development and immunohistochemical characterization of patient-derived xenograft models for muscle invasive bladder cancer.

Authors:  Abolfazl Razzaghdoust; Samad Muhammadnejad; Mahmoud Parvin; Bahram Mofid; Masoumeh Zangeneh; Abbas Basiri
Journal:  Iran J Basic Med Sci       Date:  2021-12       Impact factor: 2.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.